Indefinite Delivery Contract SPE2DR25D1102

The Indefinite Delivery Contract (IDC) SPE2DR25D1102 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract has a base period of 30 months and three 30-month option periods, with an estimated total value of $30.3 billion.

The contract was established under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) procurement, which aims to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency (DHA), Department of Defense (DoD), United States Coast Guard, and the US Naval Fleet. The contract will have at least three different primary suppliers across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet regions, as well as a separate backup supplier, to ensure resiliency and access to vital pharmaceuticals during contingencies or natural disasters. The contract is an unrestricted, fully competitive acquisition awarded on a lowest price technically acceptable (LPTA) basis.